ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HLA antigens"

  • 2017 American Transplant Congress

    Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching.

    D. Li,1 O. Timofeeva,1 M. Awwad,1 C. Cody,2 S. Najjar,2 S. Rosen-Bronson.1

    1Histocompatibility Laboratory, MedStar Georgetown University Hospital, Washington, DC; 2MedStar Heart Institute, Washington Hospital Center, Washington, DC

    Purpose: Virtual crossmatch (VXM) has been utilized in heart transplant (txp) for more than a decade. Many labs base the VXM solely on single antigen…
  • 2017 American Transplant Congress

    Validation of a Novel Computational Approach for Predicting HLA Immunogenicity Based on Quantification of Structural and Surface Electrostatic Potential Differences Between Donor and Recipient HLA.

    V. Kosmoliaptsis,1 C. Kling,2 M. Robb,3 D. Collett,3 J. Bradley,1 C. Taylor,1 D. Kabelitz,2 D. Mallon.1

    1Department of Surgery, University of Cambridge, Cambridge, United Kingdom; 2University of Kiel, Kiel, Germany; 3NHS Blood and Transplant, Bristol, United Kingdom

    Background: Our preliminary work indicates that donor HLA immunogenicity in kidney and haematopoietic stem cell transplantation can be predicted by comparative assessment of donor and…
  • 2017 American Transplant Congress

    Inhibition of Heat Shock Protein 90 Suppresses the Expression of MHC Class I Molecules, but Not MHC Class II Molecules, on Endothelial Cells in Allografts.

    T. Tanaka, T. Maehana, N. Masumori.

    Urology, Sapporo Medical University, Sapporo, Japan

    Purpose: Heat shock protein 90 (HSP90) is a ubiquitously expressed molecular chaperone that is associated with the correct activation of client proteins. Important roles of…
  • 2017 American Transplant Congress

    Positive Flow Crossmatch After Negative Virtual Crossmatch -A Single Center Experience.

    Q. Xu, S. Leckie.

    Pathology and Lab Medicine, London Health Sciences Center, London, ON, Canada

    Aims: To determine causes of Flow Cytometry crossmatch (FCXM) after a negative virtual crossmatch (VirXM), even with sensitive solid-phase antibody assay and complete HLA typings…
  • 2017 American Transplant Congress

    Using Buccal Swabs for Deceased Organ Donor HLA Typing.

    C. Muse,2 S. Longobardi,1 I. Gimferrer,1 J. Orlowski.2

    1HLA Laboratory, OU Medical Center, Oklahoma City, OK; 2LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK

    Aim: In some cases, getting enough cells from a deceased donor to perform crossmatches and DNA extraction for HLA typing is challenging. Specifically this is…
  • 2017 American Transplant Congress

    A Prospective Observational Study to Evaluate Use of a Panel of Reactive T Cell (PRT) Assay as a Pre-Transplant Marker of Rejection in Kidney Transplant Recipients.

    D. Brennan,1 L. Kayler,2 D. Wojciechowski,3 A. Limaye,4 A. Gaber,5 I. Durrant.6

    1Washington University, St. Louis, MO; 2Erie County Medical Center, Buffalo, NY; 3Massachusetts General Hospital, Boston, MA; 4Washington University, Seattle, WA; 5Houston Methodist, Houston, TX; 6Oxford Immunotec, Oxfordshire, United Kingdom

    Background:To assess risk of T cell mediated acute rejection a recently developed assay uses a panel of reactive T cell lines (PRT) to measure recipient…
  • 2017 American Transplant Congress

    Acute Antibody-Mediated Rejection in Pediatric Liver Transplantation.

    C. Eriksen,1 M. Zimmerman,1 J. Kim,1 S. Lerret,2 G. Telega,2 B. Vitola,2 J. Schiller,3 J. Hong.1

    1Dept. of Surgery, Division of Transplant, Medical College of Wisconsin, Milwaukee; 2Dept of Pediatrics, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee; 3Director, Histocompatibility Laboratory, Medical College of Wisconsin, Milwaukee

    Donor-specific antibodies (DSA) and antibody mediated rejection (AMR) are associated with decreased graft survival in pediatric liver transplantation; however, the incidence of AMR is not…
  • 2016 American Transplant Congress

    Blindspots in HLA Antibody Testing: Recognition Is First Step to Nirvana.

    A. Kher, P. Dorwal, V. Kher.

    Medanta-The Medicity, Gurgaon, Haryana, India.

    This study was conducted to assess population frequency of alleles missing from single antigen bead (SAB) panels & frequency of allelic antibodies (Abs).Methods: All positive…
  • 2016 American Transplant Congress

    Epitope Load Is Predictive of De Novo Donor Specific Antibodies Occurrence in Renal Transplant Recipients After Conversion from Cyclosporine to Everolimus.

    R. Snanoudj,1 C. Suberbielle,2 N. Kamar,3 E. Cassuto,4 S. Caillard,5 J.-L. Taupin,2 D. Anglicheau,1 C. Legendre,1 A. Hertig,6 E. Rondeau.6

    1Necker Hospital, Paris, France; 2Saint-Louis Hospital, Paris, France; 3Rangueil Hospital, Toulouse, France; 4Pasteur Hospital, Nice, France; 5CHRU, Strasbourg, France; 6Tenon Hospital, Paris, France.

    IntroductionThe degree of HLA compatibility between donor and recipient is an important risk factor of developing de novo DSA, but misjudged by the number of…
  • 2016 American Transplant Congress

    Complex Constellation of HLA Antibodies Contributes to Decreasing Trend of Transplant Rate in Candidates with 100% CPRA.

    R. Rajalingam, D. Hyon Gae, D. Kopchaliiska, O. Buenaventura, K. Cunniffe, G. Da Gente, J. Roberts.

    Immunogenetics and Transplantation Laboratory; Department of Surgery, University of California-San Francisco, San Francisco, CA.

    The key component of new KAS is offering an increased priority for sensitized candidates. While transplants (tx) have increased six-fold for recipients with a CPRA…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences